Did vitamin D increase testosterone more than placebo in this study?
The findings suggest a possible benefit, but the reported analysis does not establish that vitamin D outperformed placebo. Among 54 overweight men completing a year-long weight-reduction programme, 31 received 3,332 IU of vitamin D daily and 23 received placebo. Average total testosterone rose from 10.7 to 13.4 nmol/L with vitamin D and from 11.8 to 12.7 nmol/L with placebo. However, the researchers tested changes within each group rather than directly comparing the changes between groups. A statistically significant increase in one group, but not the other, does not itself demonstrate a treatment effect.
How does the exploratory subgroup analysis affect confidence in the testosterone findings?
These findings are exploratory rather than a definitive test of vitamin D’s effect on testosterone. The underlying trial was reported as randomised and double-blind, and each participant’s blood samples were analysed together to reduce laboratory variation. However, testosterone was not a prespecified study outcome, and this report analysed only the 54 male completers from a larger trial that initially included 62 men. The small subgroup limits precision, while excluding withdrawals leaves uncertainty about their influence. Baseline differences, including lower bioactive testosterone in the vitamin D group, also warrant an appropriately baseline-adjusted comparison between treatments.
Do the hormone changes establish improvements in symptoms or wider health?
No patient-important benefit was demonstrated: the study measured hormone concentrations, not improvements in libido, mood or muscle strength. Average starting vitamin D concentrations were in the deficiency range, and average testosterone concentrations were near the lower end of the laboratory reference range; these findings therefore cannot establish a testosterone-boosting benefit in men with adequate vitamin D or different starting hormone levels. Both groups also received a weight-reduction programme and lost similar amounts of weight, so the study examined supplementation alongside that programme. This report provides no substantive adverse-event assessment, leaving both the clinical value and safety of using this regimen specifically to raise testosterone unresolved.
Assessed 21 Sept 2026.
